Top Midday Decliners

MT Newswires Live
Oct 23

Alector (ALEC) said Tuesday its phase 3 trial of latozinemab in frontotemporal dementia caused by a progranulin gene mutation failed to meet its primary clinical endpoint.

Shares sank 47% following an increase in intraday trading volume to over 39.3 million from a daily average of about 1.3 million.

Bgin Blockchain's (BGIN) shares, priced at an initial public offering of 5 million shares at $6 each and debuted on Nasdaq on Tuesday, slumped by 16% on Wednesday, with an intraday trading volume of more than 698,000.

Netflix's (NFLX) shares sank 10% after it reported Q3 earnings late Tuesday of $5.87 per diluted share, up from $5.40 a year earlier but below the FactSet consensus analyst estimate of $6.96.

More than 11.8 million shares traded intraday compared with a daily average of about 3 million.

Price: 1.69, Change: -1.52, Percent Change: -47.35

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10